When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMRX - TFF Pharmaceuticals Readies $22 Million IPO
Amneal Pharmaceuticals Inc. Class A
Quick Take
TFF Pharmaceuticals (TFFP) has filed to raise gross proceeds of $22 million from a U.S. IPO, according to an S-1 registration statement.
The firm is focused on developing and commercializing treatments for lung-related conditions.
TFFP is proposing a fairly low valuation at IPO but the firm is still at pre-Phase 1 trial stage, so the IPO is likely more relevant for long-term hold investors.
Company & Technology
Austin, Texas-based TFF was founded in 2018 to develop and commercialize drug products for the treatment of lung diseases and conditions based on